Pre-incubation of GBM samples with the elastase inhibitor, anti-PR3 antibody and cathepsin G inhibitor all showed partial inhibition of VWF cleavage activity (Fig. 2B, lanes 4–6, respectively) with somewhat stronger inhibition when elastase and PR3 were blocked compared to cathepsin G. The gene discussed is PRTN3; the disease is glioblastoma.